Nuvve Scraps Warrant Exchange, Canceling 13.1M-Share Issuance
NVVE sits 91% above its 52-week low of $3.791 on light trading volume (0.1× avg).
Summary
Nuvve terminated its warrant exchange agreement, canceling a planned issuance of 13.1 million shares. The move removes dilution but eliminates a key restructuring step amid a cash crisis and delisting risk.
Key Events · Financing and Capital Events · NVVE
-
Warrant Exchange Agreement Terminated
The May 12, 2026 Exchange Agreement to swap existing warrants for 13.1 million common shares has been terminated effective July 15, 2026. The exchange will no longer occur.
-
Dilution Removed, Restructuring Derailed
The termination eliminates the planned issuance of 13.1 million shares, removing significant dilution, but also derails a key piece of Nuvve's capital restructuring amid a cash crisis.
-
Related Agreements Also Unwound
The Registration Rights Agreement, Certificate of Designation Amendment, SPA Amendment, ELOC Termination, and AIR Termination are all effectively terminated or no longer expected to occur.
-
Financing Toolkit Weakened
With the deal's collapse, Nuvve loses planned terminations of additional investment rights and the ELOC facility, leaving these potentially dilutive instruments in place.
Analysis · NVVE · Manufacturing
Effective July 15, 2026, Nuvve terminated the May 2026 Exchange Agreement that would have swapped existing warrants for 13.1 million common shares. The deal's collapse removes a major source of potential dilution but also eliminates a key piece of the company's restructuring efforts. With only $1.7M in cash, a going concern warning, and Nasdaq delisting threats, the company loses a planned path to clean up its capital structure. The termination also means the Certificate of Designation Amendment to remove the Series A Preferred Stock floor price is off the table, and the previously agreed terminations of additional investment rights and the ELOC facility are no longer expected to occur. This leaves Nuvve's financing toolkit significantly weakened at a critical juncture.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 35.8% of the 1190 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.45%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NVVE was trading at $7.25 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.7M. The 52-week trading range was $3.79 to $655.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.